Web Sify
Follow us on
Mail
Print

Ranbaxy launches acne drug in US

Source : REUTERS
Last Updated: Mon, Nov 26, 2012 08:25 hrs
Ranbaxy CEO quits, cites strategy rift

Ranbaxy Laboratories Ltd , India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.

The drug is in-licensed from Cipher Pharmaceuticals Inc , said Ranbaxy, controlled by Japan's Daiichi Sankyo Co <4568.T>, on Monday.


More from Sify:
blog comments powered by Disqus
  Cities   Price (10g)
  Chennai   Rs. 24500.00 (-0.33%)
  Mumbai   Rs. 25480.00 (-0.08%)
  Delhi   Rs. 25200.00 (0%)
  Kolkata   Rs. 25000.00 (0%)
  Kerala   Rs. 24400.00 (-0.41%)
  Bangalore   Rs. 24450.00 (0%)
  Hyderabad   Rs. 24580.00 (0%)
talking point on sify finance